Skip to main
SEPN
SEPN logo

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna Inc. possesses a modest enterprise value of approximately $430 million, suggesting a significant long-term upside potential of 8-10 times the current share price, particularly if its partnership with Novoproves proves successful. The company's management anticipates enhanced efficiency in executing Phase 1 trials for SEP-786 based on previous experience, which could accelerate project timelines. Additionally, if SEP-631 demonstrates similar efficacy to Xolair, which achieved nearly $3.9 billion in total sales in 2023, it has the potential to reach blockbuster status, further bolstering Septerna's financial standing in the market.

Bears say

The financial outlook for Septerna Inc. is negatively impacted by multiple risks inherent in its clinical development process, including potential delays in advancing key candidates such as SEP-631, as well as setbacks during clinical trials. Additional concerns stem from the partnership with Novo Nordisk, which may introduce uncertainties, especially in securing approvals for leading product candidates and achieving anticipated market penetration rates. Furthermore, the implications of possible long-term dilution pose additional financial risks, further exacerbated by a recently highlighted valuation gap in the obesity sector.

Septerna Inc (SEPN) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Buy based on their latest research and market trends.

According to 3 analysts, Septerna Inc (SEPN) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $27.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $27.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.